DeepMed Research

VIRGINIA COMMONWEALTH UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 10K

Market Cap: -

Website: http://www.vcu.edu

Clinical Trials

Sleep Extension to Improve Sleep Efficiency and QoL in HF With Preserved Ejection Fraction: the SLEEP-HF Pilot Study

Not Applicable

Recruiting

Conditions: Heart Failure With Preserved Ejection Fraction

Interventions: Behavioral: Customized Sleep Coaching
Behavioral: Sleep Hygiene Training

First Posted Date: 2024-08-23

Last Posted Date: 2025-04-27

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 17

Registration Number: NCT06567925

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Cardiovascular Health & Early Stress

Recruiting

Conditions: Stress

Interventions: Other: Childhood stress

First Posted Date: 2024-08-16

Last Posted Date: 2024-08-16

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 120

Registration Number: NCT06557707

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Immune Registry for BK in Kidney Transplant Recipients

Recruiting

Conditions: BK Virus Infection
Kidney Transplant; Complications

Interventions: Other: Collection of blood samples
Other: Data Collection
Other: Urine Sample

First Posted Date: 2024-08-06

Last Posted Date: 2025-02-24

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 60

Registration Number: NCT06538961

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Redefining BMI: The Body, Mind, and Inflammation Trial

Not Applicable

Not yet recruiting

Conditions: Obesity
Adiposity

Interventions: Behavioral: Integrated Lifestyle Intervention (ILI)
Behavioral: Monitoring with digital tools

First Posted Date: 2024-08-01

Last Posted Date: 2025-05-13

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 32

Registration Number: NCT06532747

Locations: 🇺🇸
Virginia Commonwealth Universtity, Richmond, Virginia, United States

Using Dichoptic Therapy to Treat Intermittent Exotropia

Not Applicable

Recruiting

Conditions: Exotropia Intermittent

Interventions: Device: Luminopia, a virtual reality headset
Other: Paper pre- survey
Other: Paper Survey

First Posted Date: 2024-07-31

Last Posted Date: 2025-02-17

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 20

Registration Number: NCT06529016

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Anti-Inflammatory Lifestyle Intervention for Emerging Adult Cancer Survivors

Not Applicable

Recruiting

Conditions: Survivorship

Interventions: Behavioral: Anti-Inflammatory Lifestyle Intervention

First Posted Date: 2024-06-04

Last Posted Date: 2025-02-24

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 19

Registration Number: NCT06442397

Locations: 🇺🇸
Virginia Commonwealth University, School of Medicine, Richmond, Virginia, United States

CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial

Phase 2

Recruiting

Conditions: Primary Brain Tumor
Astrocytoma
Oligodendroglioma
Primary Central Nervous System (CNS) Lymphoma
Meningioma
Glioblastoma

Interventions: Behavioral: Cognitive Behavioral Therapy for Insomnia

First Posted Date: 2024-06-03

Last Posted Date: 2024-07-10

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 60

Registration Number: NCT06439420

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs

Not Applicable

Recruiting

Conditions: Tachyarrhythmia

Interventions: Device: Eko Duo electronic stethoscope
Device: CORE 500 electronic stethoscope

First Posted Date: 2024-04-24

Last Posted Date: 2025-04-29

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 100

Registration Number: NCT06382207

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality

Phase 4

Recruiting

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Oral Azacitidine

First Posted Date: 2024-04-17

Last Posted Date: 2025-02-24

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 12

Registration Number: NCT06370000

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

OPTIMIZING OCULAR OUTCOMES: A DUAL-ARMED STUDY FOR PERIORBITAL BURN MANAGEMENT

Not Applicable

Not yet recruiting

Conditions: Periorbital Burns

Interventions: Drug: 5-FU/Kenalog
Drug: Steroid/Antibiotic (Maxitrol)

First Posted Date: 2024-04-12

Last Posted Date: 2025-03-26

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 10

Registration Number: NCT06362226

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy